Paradoxical psoriasiform skin eruption in paediatric patients with inflammatory bowel disease treated with tumour necrosis factor-α inhibitors
TNFi-induced psoriasiform eruptions are common in paediatric patients with IBD. The eruption may appear months or even years after treatment initiation. Almost one-third of the described patients had to replace their treatment because of a recalcitrant cutaneous eruption. This indicates that a multidisciplinary approach is required.
Authors
- Rivka Friedland (ORCID: https://orcid.org/0000-0001-8117-3656)
- Daniel Hilewitz (ORCID: https://orcid.org/0009-0000-2274-4332)
- Shiran Reiss‐Huss
- Yael Weintraub (ORCID: https://orcid.org/0000-0002-9748-2872)
- Lev Pavlovsky (ORCID: https://orcid.org/0000-0001-8400-9587)
- Dror S. Shouval (ORCID: https://orcid.org/0000-0001-5980-2954)
- Manar Matar (ORCID: https://orcid.org/0000-0002-5270-2691)
- Sharon Yacobovitz
Institutions
- Tel Aviv University (IL)
- Rabin Medical Center (IL)
- Schneider Children's Medical Center (IL)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2024-10-14
- DOI
- https://doi.org/10.1093/ced/llae432
- Citations
- 2
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.48